- Home
- SRPT vs JLS Comparison
SRPT vs JLS Comparison
Compare SRPT & JLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SRPT | JLS |
|---|---|---|
| Founded | 1980 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 103.4M |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | SRPT | JLS |
|---|---|---|
| Price | $22.37 | $18.23 |
| Analyst Decision | Hold | |
| Analyst Count | 29 | 0 |
| Target Price | ★ $26.23 | N/A |
| AVG Volume (30 Days) | ★ 3.4M | 26.6K |
| Earning Date | 11-03-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.33% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,413,715,000.00 | N/A |
| Revenue This Year | $13.83 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 47.15 | N/A |
| 52 Week Low | $10.42 | $15.48 |
| 52 Week High | $129.84 | $17.97 |
Technical Indicators
Market Signals| Indicator | SRPT | JLS |
|---|---|---|
| Relative Strength Index (RSI) | 58.63 | 30.84 |
| Support Level | $20.93 | $18.11 |
| Resistance Level | $22.85 | $18.67 |
| Average True Range (ATR) | 1.26 | 0.21 |
| MACD | 0.18 | -0.03 |
| Stochastic Oscillator | 82.19 | 18.81 |
Price Performance
Historical ComparisonAbout SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About JLS Nuveen Mortgage and Income Fund
Nuveen Mortgage And Income Fund is a diversified, closed-end management investment company. The fund invests at least fifty percent of its Managed Assets in MBS, including residential MBS and commercial MBS, and up to fifty percent in non-mortgage related ABS. Its investment objective to generate high current income through opportunistic investments in securitized credit.